Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine

© 2020 Elsevier B.V. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular liquids. - 1998. - 314(2020) vom: 15. Sept., Seite 113612
1. Verfasser: Ismail, Saba (VerfasserIn)
Weitere Verfasser: Ahmad, Sajjad, Azam, Syed Sikander
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Journal of molecular liquids
Schlagworte:Journal Article COVID-19 Immuno-informatics Molecular dynamics simulation Multi-epitope peptide vaccine construct SARS-CoV-2 Spike glycoprotein Vaccine
LEADER 01000caa a22002652c 4500
001 NLM314076867
003 DE-627
005 20250227203825.0
007 cr uuu---uuuuu
008 231225s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.molliq.2020.113612  |2 doi 
028 5 2 |a pubmed25n1046.xml 
035 |a (DE-627)NLM314076867 
035 |a (NLM)32834259 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Ismail, Saba  |e verfasserin  |4 aut 
245 1 0 |a Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine 
264 1 |c 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 11.11.2023 
500 |a published: Print-Electronic 
500 |a Citation Status PubMed-not-MEDLINE 
520 |a © 2020 Elsevier B.V. All rights reserved. 
520 |a The COVID-19 pandemic caused by SARS-CoV-2 is a public health emergency of international concern and thus calling for the development of effective and safe therapeutics and prophylactics particularly a vaccine to protect against the infection. SARS-CoV-2 spike glycoprotein is an attractive candidate for a vaccine, antibodies, and inhibitors development because of the many roles it plays in attachment, fusion and entry into the host cell. In the present investigation, we characterized the SARS-CoV-2 spike glycoprotein by immunoinformatics techniques to put forward potential B and T cell epitopes, followed by the use of epitopes in construction of a multi-epitope peptide vaccine construct (MEPVC). The MEPVC revealed robust host immune system simulation with high production of immunoglobulins, cytokines and interleukins. Stable conformation of the MEPVC with a representative innate immune TLR3 receptor was observed involving strong hydrophobic and hydrophilic chemical interactions, along with enhanced contribution from salt-bridges towards inter-molecular stability. Molecular dynamics simulation in aqueous milieu aided further in interpreting strong affinity of the MEPVC for TLR3. This stability is the attribute of several vital residues from both TLR3 and MEPVC as shown by radial distribution function (RDF) and a novel axial frequency distribution (AFD) analytical tool. Comprehensive binding free energies estimation was provided at the end that concluded major domination by electrostatic and minor from van der Waals. Summing all, the designed MEPVC has tremendous potential of providing protective immunity against COVID-19 and thus could be considered in experimental studies 
650 4 |a Journal Article 
650 4 |a COVID-19 
650 4 |a Immuno-informatics 
650 4 |a Molecular dynamics simulation 
650 4 |a Multi-epitope peptide vaccine construct 
650 4 |a SARS-CoV-2 
650 4 |a Spike glycoprotein 
650 4 |a Vaccine 
700 1 |a Ahmad, Sajjad  |e verfasserin  |4 aut 
700 1 |a Azam, Syed Sikander  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Journal of molecular liquids  |d 1998  |g 314(2020) vom: 15. Sept., Seite 113612  |w (DE-627)NLM098180800  |x 0167-7322  |7 nnas 
773 1 8 |g volume:314  |g year:2020  |g day:15  |g month:09  |g pages:113612 
856 4 0 |u http://dx.doi.org/10.1016/j.molliq.2020.113612  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 314  |j 2020  |b 15  |c 09  |h 113612